103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB5051

 

Introduced 2/8/2024, by Rep. Jenn Ladisch Douglass

 

SYNOPSIS AS INTRODUCED:
 
215 ILCS 200/52 new

    Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; or for specified prescription drugs, including insulin, human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone.


LRB103 38175 RPS 68308 b

 

 

A BILL FOR

 

HB5051LRB103 38175 RPS 68308 b

1    AN ACT concerning regulation.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Prior Authorization Reform Act is amended
5by adding Section 52 as follows:
 
6    (215 ILCS 200/52 new)
7    Sec. 52. Prior authorization prohibited. A health
8insurance issuer may not require prior authorization for:
9        (1) a prescription drug prescribed to a patient by a
10    health care professional for 6 or more consecutive months,
11    regardless of whether the prescription drug is a
12    non-preferred medication pursuant to the patient's health
13    insurance coverage;
14        (2) the following prescription drugs or the
15    therapeutic equivalent approved by the United States Food
16    and Drug Administration: insulin; human immunodeficiency
17    virus prevention medication; human immunodeficiency virus
18    treatment medication; viral hepatitis medication;
19    estrogen; and progesterone; or
20        (3) human immunodeficiency virus pre-exposure
21    prophylaxis and post-exposure prophylaxis drugs approved
22    by the United States Food and Drug Administration;
23    Truvada; Harvoni; Descovy; and Apretude.